Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement

INTRODUCTION: The rearrangement of the anaplastic lymphoma kinase (ALK) gene accounts for approximately 1%–6% of lung adenocarcinoma cases and defines a molecular subgroup of tumors characterized by clinical sensitivity to ALK inhibitors such as crizotinib. This study aimed to identify the relations...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Chin J Cancer
Auteurs principaux: Fu, Sha, Wang, Hai-Yun, Wang, Fang, Huang, Ma-Yan, Deng, Ling, Zhang, Xiao, Ye, Zu-Lu, Shao, Jian-Yong
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593362/
https://ncbi.nlm.nih.gov/pubmed/26253541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-015-0032-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires